Broca aphasia
Broca's Aphasia is a type of aphasia characterized by partial or total inability to articulate ideas or understand spoken or written language, resulting from damage to the brain's language centers. Named after the French physician Paul Broca, who first described the condition, it is also known as expressive aphasia or non-fluent aphasia.
Overview[edit | edit source]
Broca's aphasia is a neurological disorder that affects a person's ability to speak and communicate effectively. It is caused by damage to the Broca's area, a region in the frontal lobe of the brain that is involved in language processing. This damage can occur due to a stroke, brain tumor, head injury, or other neurological conditions.
Symptoms[edit | edit source]
People with Broca's aphasia often have difficulty with speech production, but their comprehension can be relatively preserved. Symptoms may include:
- Difficulty forming complete sentences
- Omitting small words such as "is" or "the"
- Speaking in short phrases that make sense but are produced with great effort
- Problems with writing
- Difficulty understanding complex sentences
Diagnosis[edit | edit source]
The diagnosis of Broca's aphasia is typically made by a neurologist or a speech-language pathologist through a series of language and speech tests. Brain imaging techniques such as MRI or CT scan may also be used to identify damage to the Broca's area.
Treatment[edit | edit source]
While there is no cure for Broca's aphasia, treatment can help improve communication skills and manage symptoms. This often involves speech therapy, where patients work with a speech-language pathologist to improve their language abilities. Other strategies may include the use of assistive technology for communication, such as apps or devices that can help produce speech.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD